Loading
No insider purchase over the last 90 days. The latest, by Baker Biotech Capital (GP), LLC, was filed 14 Feb 2012.
Pharmacyclics Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Pharmacyclics Inc in twelve months, the latest record being from 28 May 2015.
Over the whole record (from 2006), the tally stands at 250 purchases and 96 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
25 of 566 declarations